← Leaderboards
Todd E. Golde
Mayo Clinic Coll Of Med, Jacksonville
$22,621,576
Attributed
$32,724,439
Total exposure
22
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.7M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$69,944,449 · 25
By mechanism
U01$25,262,476 · 3
R01$12,839,802 · 7
RF1$8,737,147 · 3
P50$8,639,029 · 3
P30$7,035,367 · 2
P01$6,193,078 · 5
Top collaborators
- Nilufer Ertekin-Taner19 shared
- Nathan D Price16 shared
- Steven G Younkin7 shared
- Yona R Levites5 shared
- Cory Funk4 shared
- Jada M Lewis3 shared
- Stefan Prokop3 shared
- Jennifer Lynn Bizon2 shared
Most similar at Mayo Clinic Coll Of Med, Jacksonville
Same institution · by research overlap
- Jada M Lewis$8,224,231
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBaseBrainPathologyAmyloidPlayIn VivoMouse ModelInsightDesignTherapeutic TargetMediatingBiologicalPathway InteractionsImmuneDepositionTau ProteinsMedicalNerve DegenerationGenesImmunotherapyProgramsCollaborations
Grant awards (103)
Searching for the Goldilocks Zone of Innate Immunity in Alzheimer's Disease$989,879
R01 · FY2025 · AG · contact PI
Amyloidosis associated proteins in Alzheimerâs disease pathogenesis$739,630
R01 · FY2025 · AG
Alzheimer's Disease Big Data to Biology Training Program (ADBDB-TP)$575,400
T32 · FY2025 · AG · contact PI
Searching for the Goldilocks Zone of Innate Immunity in Alzheimer's Disease$1,010,081
R01 · FY2024 · AG · contact PI
Amyloidosis associated proteins in Alzheimerâs disease pathogenesis$757,775
R01 · FY2024 · AG
Alzheimer's Disease Big Data to Biology Training Program (ADBDB-TP)$585,650
T32 · FY2024 · AG · contact PI
A Systems Approach to Targeting Innate Immunity in AD$2,421,378
U01 · FY2022 · AG
A Systems Approach to Targeting Innate Immunity in AD$391,250
U01 · FY2022 · AG
1Florida Alzheimer's Disease Research Center$70,424
P30 · FY2022 · AG · contact PI
A Systems Approach to Targeting Innate Immunity in AD$3,188,314
U01 · FY2021 · AG
1Florida Alzheimer's Disease Research Center$2,987,182
P30 · FY2021 · AG · contact PI
Amyloidosis associated proteins in Alzheimerâs disease pathogenesis$2,290,100
RF1 · FY2021 · AG
1Florida Alzheimer's Disease Research Center Administrative Core$183,536
P30 · FY2021 · AG · contact PI
Social Determinants of Health, Race/Ethnicity, and White Matter Hyperintensities$52,818
P30 · FY2021 · AG · contact PI
A Systems Approach to Targeting Innate Immunity in AD$3,233,653
U01 · FY2020 · AG
1Florida Alzheimer's Disease Research Center$3,039,647
P30 · FY2020 · AG · contact PI
ConProject-001$1,197,976
U01 · FY2020 · AG · contact PI
A Systems Approach to Targeting Innate Immunity in AD$1,197,976
U01 · FY2020 · AG · contact PI
1Florida Alzheimer's Disease Research Center Administrative Core$547,759
P30 · FY2020 · AG · contact PI
A Systems Approach to Targeting Innate Immunity in AD$455,584
U01 · FY2020 · AG
ConProject-001$451,500
U01 · FY2020 · AG · contact PI
A Systems Approach to Targeting Innate Immunity in AD$451,500
U01 · FY2020 · AG · contact PI
COVID-19, Social Distancing, and Cognitive Impairment in 1Florida ADRC participants$154,001
P30 · FY2020 · AG · contact PI
Immunotherapy targeting the HPA axis in Alzheimerâs disease$2,689,784
RF1 · FY2019 · AG · contact PI
Elucidating factors that modulate tauopathy and cellular degeneration to guide therapeutic development$2,473,595
RF1 · FY2019 · AG
A Systems Approach to Targeting Innate Immunity in AD$1,586,898
U01 · FY2019 · AG · contact PI
University of Florida - Mt. Sinai Medical Center AD Research Center$1,405,272
P50 · FY2019 · AG · contact PI
Immunotherapy targeting the HPA axis in Alzheimer's disease$1,283,668
RF1 · FY2019 · AG · contact PI
A Systems Approach to Targeting Innate Immunity in AD$388,794
U01 · FY2019 · AG · contact PI
Identification of Peripheral Transcripts as Predictive Biomarkers in Alzheimerâs Disease (AD)$197,184
U01 · FY2019 · AG · contact PI
Core A: Administrative Core$166,323
P50 · FY2019 · AG · contact PI
A Systems Approach to Targeting Innate Immunity in AD$1,613,148
U01 · FY2018 · AG · contact PI
University of Florida - Mt. Sinai Medical Center AD Research Center$1,412,772
P50 · FY2018 · AG · contact PI
Immune-Mediated Mechanisms underlying CNS Abeta Clearance$436,145
R01 · FY2018 · AG · contact PI
Core A: Administrative Core$160,309
P50 · FY2018 · AG · contact PI
A system approach to targeting innate immunity in AD$1,765,056
U01 · FY2017 · AG · contact PI
University of Florida - Mt. Sinai Medical Center AD Research Center$1,413,712
P50 · FY2017 · AG · contact PI
Immune-Mediated Mechanisms underlying CNS Abeta Clearance$436,145
R01 · FY2017 · AG · contact PI
Profiling y-secretase activity and inhibition$335,758
P01 · FY2017 · CA · contact PI
Project 1$171,946
P50 · FY2017 · AG · contact PI
Core A: Administrative Core$162,703
P50 · FY2017 · AG · contact PI
Admin Supplement for University of Florida -Mt. Sinai Medical Center AD Research Center$99,741
P50 · FY2017 · AG · contact PI
A system approach to targeting innate immunity in AD$1,592,165
U01 · FY2016 · AG · contact PI
University of Florida - Mt. Sinai Medical Center AD Research Center$1,449,508
P50 · FY2016 · AG · contact PI
Immune-Mediated Mechanisms underlying CNS Abeta Clearance$436,145
R01 · FY2016 · AG · contact PI
Profiling y-secretase activity and inhibition$335,758
P01 · FY2016 · CA · contact PI
Project 1$166,332
P50 · FY2016 · AG · contact PI
Core A: Administrative Core$164,580
P50 · FY2016 · AG · contact PI
A system approach to targeting innate immunity in AD$156,500
U01 · FY2016 · AG · contact PI
A system approach to targeting innate immunity in AD$1,597,190
U01 · FY2015 · AG · contact PI
University of Florida - Mt. Sinai Medical Center AD Research Center$1,521,933
P50 · FY2015 · AG · contact PI
Immune-Mediated Mechanisms underlying CNS Abeta Clearance$423,059
R01 · FY2015 · AG · contact PI
Profiling y-secretase activity and inhibition$335,403
P01 · FY2015 · CA · contact PI
Project 1$173,832
P50 · FY2015 · AG · contact PI
Core A: Administrative Core$170,066
P50 · FY2015 · AG · contact PI
A system approach to targeting innate immunity in AD$1,665,226
U01 · FY2014 · AG · contact PI
Immune-Mediated Mechanisms underlying CNS Abeta Clearance$435,633
R01 · FY2014 · AG · contact PI
Profiling y-secretase activity and inhibition$325,686
P01 · FY2014 · CA · contact PI
A system approach to targeting innate immunity in AD$109,143
U01 · FY2014 · AG · contact PI
A system approach to targeting innate immunity in AD$1,602,041
U01 · FY2013 · AG · contact PI
TARGET IDENTIFICATION AND MECHANISMS OF ACTIONS OF y-SECRETASE MODULATORS$458,839
P01 · FY2013 · AG · contact PI
Profiling y-secretase activity and inhibition$346,169
P01 · FY2013 · CA · contact PI
TARGET IDENTIFICATION AND MECHANISMS OF ACTIONS OF y-SECRETASE MODULATORS$333,069
P01 · FY2012 · AG · contact PI
Immune-Mediated Mechanisms Underlying CNS abeta Clearance$285,786
R01 · FY2012 · AG · contact PI
TARGET IDENTIFICATION AND MECHANISMS OF ACTIONS OF y-SECRETASE MODULATORS$679,867
P01 · FY2011 · AG · contact PI
Immune-Mediated Mechanisms Underlying CNS abeta Clearance$285,786
R01 · FY2011 · AG · contact PI
Role of Rer1 in the regulation of gamma-secretase trafficking and activity$228,628
R01 · FY2011 · AG · contact PI
TARGET IDENTIFICATION AND MECHANISMS OF ACTIONS OF y-SECRETASE MODULATORS$509,567
P01 · FY2010 · AG · contact PI
AB AND BEYOND: Y-SECRETASE A DRUG TARGET FOR CNS DISEASE$306,658
P01 · FY2010 · AG · contact PI
Immune-Mediated Mechanisms Underlying CNS abeta Clearance$297,322
R01 · FY2010 · AG · contact PI
CHEMISTRY CORE$119,050
P01 · FY2010 · AG · contact PI
TARGET IDENTIFICATION AND MECHANISMS OF ACTIONS OF y-SECRETASE MODULATORS$466,519
P01 · FY2009 · AG · contact PI
Immune-Mediated Mechanisms Underlying CNS abeta Clearance$313,650
R01 · FY2009 · AG · contact PI
AB AND BEYOND: Y-SECRETASE A DRUG TARGET FOR CNS DISEASE$298,706
P01 · FY2009 · AG · contact PI
CHEMISTRY CORE$120,377
P01 · FY2009 · AG · contact PI
Abeta42 Altering Compounds: Mechanisms of Action$532,692
R01 · FY2008 · AG · contact PI
Gamma Secretases in Alzheimers Disease$320,011
R01 · FY2008 · NS · contact PI
Immune-Mediated Mechanisms Underlying CNS abeta Clearance$313,650
R01 · FY2008 · AG · contact PI
AB AND BEYOND: Y-SECRETASE A DRUG TARGET FOR CNS DISEASE$288,081
P01 · FY2008 · AG · contact PI
CHEMISTRY CORE$120,481
P01 · FY2008 · AG · contact PI
Gamma Secretases in Alzheimers Disease$320,011
R01 · FY2007 · NS · contact PI
AB AND BEYOND: Y-SECRETASE A DRUG TARGET FOR CNS DISEASE$292,835
P01 · FY2007 · AG · contact PI
CHEMISTRY CORE$122,544
P01 · FY2007 · AG · contact PI
Gamma Secretases in Alzheimers Disease$329,569
R01 · FY2006 · NS · contact PI
AB AND BEYOND: Y-SECRETASE A DRUG TARGET FOR CNS DISEASE$277,327
P01 · FY2006 · AG · contact PI
CHEMISTRY CORE$120,384
P01 · FY2006 · AG · contact PI
Immune-Mediated Mechanisms Underlying CNS Abeta Clearance$362,080
R01 · FY2005 · AG
Gamma Secretases in Alzheimers Disease$337,500
R01 · FY2005 · NS
Gamma Secretases in Alzheimers Disease$312,500
R01 · FY2004 · NS
Immune-Mediated Mechanisms Underlying CNS Abeta Clearance$269,500
R01 · FY2004 · AG
In situ therapeutic anti-AB delivery/adenoviral vectors$231,450
R01 · FY2004 · AG
Immune-Mediated Mechanisms Underlying CNS Abeta Clearance$89,106
R01 · FY2004 · AG
Immune-Mediated Mechanisms Underlying CNS Abeta Clearance$269,500
R01 · FY2003 · AG
In situ therapeutic anti-AB delivery/adenoviral vectors$231,450
R01 · FY2003 · AG
Y-SECRETASES IN ALZHEIMER'S DISEASE$306,000
R01 · FY2002 · NS
In situ therapeutic anti-AB delivery/adenoviral vectors$243,919
R01 · FY2002 · AG
IMMUNE-MEDIATED MECHANISMS UNDERLAYING CNS AB CLEARANCE$229,500
R01 · FY2002 · AG
NOVEL MECHANISMS OF NSAID ACTION IN ALZHEIMER DISEASE$0
P01 · FY2002 · AG
Y-SECRETASES IN ALZHEIMER'S DISEASE$306,000
R01 · FY2001 · NS
IMMUNE-MEDIATED MECHANISMS UNDERLAYING CNS AB CLEARANCE$229,500
R01 · FY2001 · AG
GAMMA-SECRETASES IN ALZHEIMER'S DISEASE$300,700
R01 · FY2000 · NS
IMMUNE-MEDIATED MECHANISMS UNDERLAYING CNS AB CLEARANCE$229,500
R01 · FY2000 · AG
PNA'S AS MODULATORS OF PRESENILIN EXPRESSION$76,500
R03 · FY2000 · AG